References
1. Bustamante J, Boisson-Dupuis S, Abel L, Casanova JL. Mendelian
susceptibility to mycobacterial disease: genetic, immunological, and
clinical features of inborn errors of IFN-gamma immunity. Semin
Immunol. 2014;26(6):454-470.
2. Kerner G, Rosain J, Guerin A, et al. Inherited human IFN-gamma
deficiency underlies mycobacterial disease. J Clin Invest.2020;130(6):3158-3171.
3. McKusick‐Nathans Institute of Genetic Medicine JHU, Baltimore, MD.
OMIM. Online Mendelian Inheritance in Man, OMIM®. Retrieved from
https://omim.org/. 2021.
4. van de Vosse E, van Dissel JT. IFN-gammaR1 defects: Mutation update
and description of the IFNGR1 variation database. Hum Mutat.2017;38(10):1286-1296.
5. Wu UI, Holland SM. Host susceptibility to non-tuberculous
mycobacterial infections. Lancet Infect Dis. 2015;15(8):968-980.
6. French MA, Tangye SG. The Next Generation of Diagnostic Tests for
Primary Immunodeficiency Disorders. The Journal of Infectious
Diseases. 2019;221(8):1232-1234.
7. Chen X, Vinkemeier U, Zhao Y, Jeruzalmi D, Darnell JE, Jr., Kuriyan
J. Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to
DNA. Cell. 1998;93(5):827-839.
8. Basab Roy ZZ, Gary D. Stormo. Quantitative specificity of STAT1 and
several variants. Nucleic Acids Research. 2017;45(14):8199-8207.
TablesNone.
Figure legends